advertisement
Cornea 36
Showing records 1 to 25 | Display all abstracts in Cornea95349 Safety of KPI-121 Ophthalmic Suspension 0.25% in Patients With Dry Eye Disease: A Pooled Analysis of 4 Multicenter, Randomized, Vehicle-Controlled Studies
Korenfeld M
Cornea 2021; 40: 564-570
95372 Limbal Stem Cell Deficiency: Demographics and Clinical Characteristics of a Large Retrospective Series at a Single Tertiary Referral Center
Cheung AY
Cornea 2021; 0:
95245 Treatment of Progressive Scleromalacia Perforans by Tectonic Enhancement With Lyophilized Equine Pericardium
Droutsas K
Cornea 2021; 40: 648-651
94858 Reliability of Several Glaucoma Tests in Patients With Boston Type 1 Keratoprosthesis
Akpek EK
Cornea 2022; 41: 310-316
95373 Indications for Wear, Visual Outcomes, and Complications of Custom Imprint 3D Scanned Scleral Contact Lens Use
Silverman JIM
Cornea 2021; 40: 596-602
95237 Long-Term Visual Outcomes and Clinical Course of Patients With Peters Anomaly
Elbaz U
Cornea 2021; 40: 822-830
95349 Safety of KPI-121 Ophthalmic Suspension 0.25% in Patients With Dry Eye Disease: A Pooled Analysis of 4 Multicenter, Randomized, Vehicle-Controlled Studies
Nichols KK
Cornea 2021; 40: 564-570
95372 Limbal Stem Cell Deficiency: Demographics and Clinical Characteristics of a Large Retrospective Series at a Single Tertiary Referral Center
Sarnicola E
Cornea 2021; 0:
95245 Treatment of Progressive Scleromalacia Perforans by Tectonic Enhancement With Lyophilized Equine Pericardium
Giachos I
Cornea 2021; 40: 648-651
95373 Indications for Wear, Visual Outcomes, and Complications of Custom Imprint 3D Scanned Scleral Contact Lens Use
Huffman JM
Cornea 2021; 40: 596-602
94858 Reliability of Several Glaucoma Tests in Patients With Boston Type 1 Keratoprosthesis
Karakus S
Cornea 2022; 41: 310-316
95237 Long-Term Visual Outcomes and Clinical Course of Patients With Peters Anomaly
Strungaru H; Strungaru H
Cornea 2021; 40: 822-830
95373 Indications for Wear, Visual Outcomes, and Complications of Custom Imprint 3D Scanned Scleral Contact Lens Use
Zimmerman MB
Cornea 2021; 40: 596-602
95245 Treatment of Progressive Scleromalacia Perforans by Tectonic Enhancement With Lyophilized Equine Pericardium
Katsiampoula V
Cornea 2021; 40: 648-651
94858 Reliability of Several Glaucoma Tests in Patients With Boston Type 1 Keratoprosthesis
Yohannan J
Cornea 2022; 41: 310-316
95237 Long-Term Visual Outcomes and Clinical Course of Patients With Peters Anomaly
Mireskandari K
Cornea 2021; 40: 822-830
95349 Safety of KPI-121 Ophthalmic Suspension 0.25% in Patients With Dry Eye Disease: A Pooled Analysis of 4 Multicenter, Randomized, Vehicle-Controlled Studies
Goldberg D
Cornea 2021; 40: 564-570
95372 Limbal Stem Cell Deficiency: Demographics and Clinical Characteristics of a Large Retrospective Series at a Single Tertiary Referral Center
Denny MR
Cornea 2021; 0:
95373 Indications for Wear, Visual Outcomes, and Complications of Custom Imprint 3D Scanned Scleral Contact Lens Use
Ling JJ
Cornea 2021; 40: 596-602
95372 Limbal Stem Cell Deficiency: Demographics and Clinical Characteristics of a Large Retrospective Series at a Single Tertiary Referral Center
Sepsakos L
Cornea 2021; 0:
95349 Safety of KPI-121 Ophthalmic Suspension 0.25% in Patients With Dry Eye Disease: A Pooled Analysis of 4 Multicenter, Randomized, Vehicle-Controlled Studies
Evans D
Cornea 2021; 40: 564-570
95237 Long-Term Visual Outcomes and Clinical Course of Patients With Peters Anomaly
Stephens D
Cornea 2021; 40: 822-830
95245 Treatment of Progressive Scleromalacia Perforans by Tectonic Enhancement With Lyophilized Equine Pericardium
Kourti P
Cornea 2021; 40: 648-651
94858 Reliability of Several Glaucoma Tests in Patients With Boston Type 1 Keratoprosthesis
Jabbour S
Cornea 2022; 41: 310-316
95349 Safety of KPI-121 Ophthalmic Suspension 0.25% in Patients With Dry Eye Disease: A Pooled Analysis of 4 Multicenter, Randomized, Vehicle-Controlled Studies
Sall K
Cornea 2021; 40: 564-570